SCHEMBL2280994

SCHEMBL2280994

CCC=CCCCCCCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.64
TRPV1 Q8NER1 1/20 0.64
TERT O14746 3/20 0.54
PTPN1 P18031 3/20 0.54
PPARG P37231 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
TOP1 P11387 3/20 0.54
CYP1A2 P05177 2/20 0.54
MAPT P10636 2/20 0.54
CYP2C19 P33261 2/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
KMT2A Q03164 2/20 0.54
GMNN O75496 1/20 0.54
USP2 O75604 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
CYP2C9 P11712 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613659 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL11068891 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855790 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854474 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854469 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1898598 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL25433701 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854588 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL11068887 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1003229 1.00 FAAH (0.64) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
US-20250110112-A1 METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 THE TRUSTEES OF INDIANA UNIVERSITY 2025-04-03 US claimed
CN-119371641-A Cyclic olefin ring-opening polymer and hydride thereof 杭州睿丰融创科技有限公司 2025-01-28 CN claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
CN-112209807-B 11-Halo-3-undecene compound, process for producing the same, and process for producing 9-dodecenal compound 信越化学工业株式会社 2024-08-06 CN claimed
WO-2024073678-A2 PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE OMEGA THERAPEUTICS, INC. (US) 2024-04-04 WO claimed
CN-117756986-A Cycloolefin copolymer, preparation method thereof, cycloolefin copolymer hydride and optical material 杭州睿丰融创科技有限公司 2024-03-26 CN claimed
CN-117363602-A Tobacco sesquiterpene synthase NtTPS126 and application thereof 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 2024-01-09 CN claimed
WO-2023225621-A2 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS OMEGA THERAPEUTICS, INC. (US) 2023-11-23 WO claimed
WO-2023004010-A2 METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 THE TRUSTEES OF INDIANA UNIVERSITY (US) 2023-01-26 WO claimed
US-10641740-B2 Ultrasound coupling material and method of use SENSOR NETWORKS, INC. (US) 2020-05-05 US claimed
US-20180196011-A1 ULTRASOUND COUPLING MATERIAL AND METHOD OF USE EDDYFI UK LIMITED (FORMERLY SILVERWING (U.K.) LIMITED (GB) 2018-07-12 US claimed
EP-4747303-A2 DISTILLATION OF PLASTIC WASTE TO FORM WATERPROOFING PRODUCTS Fairway Cost Consultancy Limited (GB) 2026-05-27 EP disclosed
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US disclosed
EP-3881048-B1 DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDS LETAT FRANCAIS REPRESENTE PAR LE MINI DE LINTERIEUR (FR) 2026-05-06 EP disclosed
CN-1059729-A Novel polypeptide compound and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1992-03-25 CN disclosed
CN-1046529-A Carbostyril derivative OTSUKA PHARMA CO LTD (JP) 1990-10-31 CN disclosed
CN-1033892-A Magnetooptical recording media MITSUI PETROCHEMICAL IND (JP) 1989-07-12 CN disclosed
CN-85105099-A The method for preparing aldehyde 1986-12-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS NSUN3, NSUN2, LDLR FAAH 3270/4885TRPV1 3541/4885TERT 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.